LWANC
FLGT icon

Laurel Wealth Advisors (North Carolina)’s Fulgent Genetics FLGT Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$3K – 566
2022
Q2 		$3K Hold
50
– – ﹤0.01% 497
2022
Q1 		$3K Hold
50
– – ﹤0.01% 540
2021
Q4 		$5K Hold
50
– – ﹤0.01% 483
2021
Q3 		$4K Sell
50
-50
-50% -$4.54K ﹤0.01% 508
2021
Q2 		$9K Hold
100
– – ﹤0.01% 468
2021
Q1 		$10K Buy
100
+50
+100% +$5.16K ﹤0.01% 427
2020
Q4 		$3K Buy
+50
New +$2.09K ﹤0.01% 516

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s FLGT Position: Q3 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of Fulgent Genetics (FLGT) in Q3 2022, closing a stake of 50 shares — an estimated $3K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in FLGT in Q4 2020 and held it in 7 quarters. The position peaked at $10K in Q1 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Fulgent Genetics position as of Q3 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 50 Fulgent Genetics shares in Q3 2022, an estimated $3K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Fulgent Genetics in Q4 2020 and held it in 7 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Fulgent Genetics position peaked at $10K in Q1 2021.
  • 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2022, filed 15 Nov 2022.